Rosetta Genomics, GeneKor Expand Distribution Agreement | GenomeWeb

NEW YORK (GenomeWeb News) – Rosetta Genomics today said that its distribution agreement with GeneKor Medical has been expanded to include Romania and Turkey.

GeneKor now has the exclusive sales and marketing rights to Rosetta Genomics' microRNA-based cancer testing services in Romania, and non-exclusive rights in Turkey. The companies originally inked a distribution deal covering Greece in 2010.

Financial and other terms of today's deal were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: weighting scheme increases GWAS power, and more.

Marc Tessier-Lavigne is to be the next president of Stanford University.

Walgreens has given Theranos 30 days to fix its lab issues, the Wall Street Journal reports.

Journals and research funding agencies pledge to enable the sharing of Zika virus research.